China Lower GI Series Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the China Lower GI Series market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Lower GI Series market. Detailed analysis of key players, along with key growth strategies adopted by Lower GI Series industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Peacehealth

    • Ironwood Pharmaceuticals

    • Astrazeneca

    • Eisai

    • Novadaq

    • Purdue Pharma

    • Cadila Pharmaceuticals

    By Type:

    • Double-Contrast

    • Single-Contrast

    By End-User:

    • Gastroenteritis

    • Colon Polyps

    • Tumor

    • Strictures Crohn's Disease

    • Ulcerative Colitis

    • Others

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Lower GI Series Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Lower GI Series Market Size and Growth Rate of Double-Contrast from 2016 to 2027

    • 1.3.2 China Lower GI Series Market Size and Growth Rate of Single-Contrast from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Lower GI Series Market Size and Growth Rate of Gastroenteritis from 2016 to 2027

    • 1.4.2 China Lower GI Series Market Size and Growth Rate of Colon Polyps from 2016 to 2027

    • 1.4.3 China Lower GI Series Market Size and Growth Rate of Tumor from 2016 to 2027

    • 1.4.4 China Lower GI Series Market Size and Growth Rate of Strictures Crohn's Disease from 2016 to 2027

    • 1.4.5 China Lower GI Series Market Size and Growth Rate of Ulcerative Colitis from 2016 to 2027

    • 1.4.6 China Lower GI Series Market Size and Growth Rate of Others from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Lower GI Series Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Lower GI Series Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Lower GI Series Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Lower GI Series Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Lower GI Series Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Lower GI Series Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Lower GI Series Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Lower GI Series Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Lower GI Series by Major Types

    • 3.4.1 Market Size and Growth Rate of Double-Contrast

    • 3.4.2 Market Size and Growth Rate of Single-Contrast

    4 Segmentation of Lower GI Series Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Lower GI Series by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Lower GI Series in Gastroenteritis

    • 4.4.2 Market Size and Growth Rate of Lower GI Series in Colon Polyps

    • 4.4.3 Market Size and Growth Rate of Lower GI Series in Tumor

    • 4.4.4 Market Size and Growth Rate of Lower GI Series in Strictures Crohn's Disease

    • 4.4.5 Market Size and Growth Rate of Lower GI Series in Ulcerative Colitis

    • 4.4.6 Market Size and Growth Rate of Lower GI Series in Others

    5 Market Analysis by Regions

    • 5.1 China Lower GI Series Production Analysis by Regions

    • 5.2 China Lower GI Series Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Lower GI Series Landscape Analysis

    • 6.1 North China Lower GI Series Landscape Analysis by Major Types

    • 6.2 North China Lower GI Series Landscape Analysis by Major End-Users

    7 Central China Lower GI Series Landscape Analysis

    • 7.1 Central China Lower GI Series Landscape Analysis by Major Types

    • 7.2 Central China Lower GI Series Landscape Analysis by Major End-Users

    8 South China Lower GI Series Landscape Analysis

    • 8.1 South China Lower GI Series Landscape Analysis by Major Types

    • 8.2 South China Lower GI Series Landscape Analysis by Major End-Users

    9 East China Lower GI Series Landscape Analysis

    • 9.1 East China Lower GI Series Landscape Analysis by Major Types

    • 9.2 East China Lower GI Series Landscape Analysis by Major End-Users

    10 Northeast China Lower GI Series Landscape Analysis

    • 10.1 Northeast China Lower GI Series Landscape Analysis by Major Types

    • 10.2 Northeast China Lower GI Series Landscape Analysis by Major End-Users

    11 Southwest China Lower GI Series Landscape Analysis

    • 11.1 Southwest China Lower GI Series Landscape Analysis by Major Types

    • 11.2 Southwest China Lower GI Series Landscape Analysis by Major End-Users

    12 Northwest China Lower GI Series Landscape Analysis

    • 12.1 Northwest China Lower GI Series Landscape Analysis by Major Types

    • 12.2 Northwest China Lower GI Series Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 Peacehealth

      • 13.1.1 Peacehealth Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Ironwood Pharmaceuticals

      • 13.2.1 Ironwood Pharmaceuticals Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Astrazeneca

      • 13.3.1 Astrazeneca Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Eisai

      • 13.4.1 Eisai Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Novadaq

      • 13.5.1 Novadaq Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Purdue Pharma

      • 13.6.1 Purdue Pharma Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 Cadila Pharmaceuticals

      • 13.7.1 Cadila Pharmaceuticals Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Lower GI Series Market Size and Growth Rate of Double-Contrast from 2016 to 2027

    • Figure China Lower GI Series Market Size and Growth Rate of Single-Contrast from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Lower GI Series Market Size and Growth Rate of Gastroenteritis from 2016 to 2027

    • Figure China Lower GI Series Market Size and Growth Rate of Colon Polyps from 2016 to 2027

    • Figure China Lower GI Series Market Size and Growth Rate of Tumor from 2016 to 2027

    • Figure China Lower GI Series Market Size and Growth Rate of Strictures Crohn's Disease from 2016 to 2027

    • Figure China Lower GI Series Market Size and Growth Rate of Ulcerative Colitis from 2016 to 2027

    • Figure China Lower GI Series Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Lower GI Series Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Lower GI Series Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Lower GI Series Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Lower GI Series Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Lower GI Series Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Lower GI Series Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Lower GI Series Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Lower GI Series Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Lower GI Series

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Lower GI Series by Different Types from 2016 to 2027

    • Table Consumption Share of Lower GI Series by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Double-Contrast

    • Figure Market Size and Growth Rate of Single-Contrast

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Lower GI Series by Different End-Users from 2016 to 2027

    • Table Consumption Share of Lower GI Series by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Gastroenteritis

    • Figure Market Size and Growth Rate of Colon Polyps

    • Figure Market Size and Growth Rate of Tumor

    • Figure Market Size and Growth Rate of Strictures Crohn's Disease

    • Figure Market Size and Growth Rate of Ulcerative Colitis

    • Figure Market Size and Growth Rate of Others

    • Table China Lower GI Series Production by Regions

    • Table China Lower GI Series Production Share by Regions

    • Figure China Lower GI Series Production Share by Regions in 2016

    • Figure China Lower GI Series Production Share by Regions in 2021

    • Figure China Lower GI Series Production Share by Regions in 2027

    • Table China Lower GI Series Consumption by Regions

    • Table China Lower GI Series Consumption Share by Regions

    • Figure China Lower GI Series Consumption Share by Regions in 2016

    • Figure China Lower GI Series Consumption Share by Regions in 2021

    • Figure China Lower GI Series Consumption Share by Regions in 2027

    • Table North China Lower GI Series Consumption by Types from 2016 to 2027

    • Table North China Lower GI Series Consumption Share by Types from 2016 to 2027

    • Figure North China Lower GI Series Consumption Share by Types in 2016

    • Figure North China Lower GI Series Consumption Share by Types in 2021

    • Figure North China Lower GI Series Consumption Share by Types in 2027

    • Table North China Lower GI Series Consumption by End-Users from 2016 to 2027

    • Table North China Lower GI Series Consumption Share by End-Users from 2016 to 2027

    • Figure North China Lower GI Series Consumption Share by End-Users in 2016

    • Figure North China Lower GI Series Consumption Share by End-Users in 2021

    • Figure North China Lower GI Series Consumption Share by End-Users in 2027

    • Table Central China Lower GI Series Consumption by Types from 2016 to 2027

    • Table Central China Lower GI Series Consumption Share by Types from 2016 to 2027

    • Figure Central China Lower GI Series Consumption Share by Types in 2016

    • Figure Central China Lower GI Series Consumption Share by Types in 2021

    • Figure Central China Lower GI Series Consumption Share by Types in 2027

    • Table Central China Lower GI Series Consumption by End-Users from 2016 to 2027

    • Table Central China Lower GI Series Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Lower GI Series Consumption Share by End-Users in 2016

    • Figure Central China Lower GI Series Consumption Share by End-Users in 2021

    • Figure Central China Lower GI Series Consumption Share by End-Users in 2027

    • Table South China Lower GI Series Consumption by Types from 2016 to 2027

    • Table South China Lower GI Series Consumption Share by Types from 2016 to 2027

    • Figure South China Lower GI Series Consumption Share by Types in 2016

    • Figure South China Lower GI Series Consumption Share by Types in 2021

    • Figure South China Lower GI Series Consumption Share by Types in 2027

    • Table South China Lower GI Series Consumption by End-Users from 2016 to 2027

    • Table South China Lower GI Series Consumption Share by End-Users from 2016 to 2027

    • Figure South China Lower GI Series Consumption Share by End-Users in 2016

    • Figure South China Lower GI Series Consumption Share by End-Users in 2021

    • Figure South China Lower GI Series Consumption Share by End-Users in 2027

    • Table East China Lower GI Series Consumption by Types from 2016 to 2027

    • Table East China Lower GI Series Consumption Share by Types from 2016 to 2027

    • Figure East China Lower GI Series Consumption Share by Types in 2016

    • Figure East China Lower GI Series Consumption Share by Types in 2021

    • Figure East China Lower GI Series Consumption Share by Types in 2027

    • Table East China Lower GI Series Consumption by End-Users from 2016 to 2027

    • Table East China Lower GI Series Consumption Share by End-Users from 2016 to 2027

    • Figure East China Lower GI Series Consumption Share by End-Users in 2016

    • Figure East China Lower GI Series Consumption Share by End-Users in 2021

    • Figure East China Lower GI Series Consumption Share by End-Users in 2027

    • Table Northeast China Lower GI Series Consumption by Types from 2016 to 2027

    • Table Northeast China Lower GI Series Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Lower GI Series Consumption Share by Types in 2016

    • Figure Northeast China Lower GI Series Consumption Share by Types in 2021

    • Figure Northeast China Lower GI Series Consumption Share by Types in 2027

    • Table Northeast China Lower GI Series Consumption by End-Users from 2016 to 2027

    • Table Northeast China Lower GI Series Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Lower GI Series Consumption Share by End-Users in 2016

    • Figure Northeast China Lower GI Series Consumption Share by End-Users in 2021

    • Figure Northeast China Lower GI Series Consumption Share by End-Users in 2027

    • Table Southwest China Lower GI Series Consumption by Types from 2016 to 2027

    • Table Southwest China Lower GI Series Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Lower GI Series Consumption Share by Types in 2016

    • Figure Southwest China Lower GI Series Consumption Share by Types in 2021

    • Figure Southwest China Lower GI Series Consumption Share by Types in 2027

    • Table Southwest China Lower GI Series Consumption by End-Users from 2016 to 2027

    • Table Southwest China Lower GI Series Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Lower GI Series Consumption Share by End-Users in 2016

    • Figure Southwest China Lower GI Series Consumption Share by End-Users in 2021

    • Figure Southwest China Lower GI Series Consumption Share by End-Users in 2027

    • Table Northwest China Lower GI Series Consumption by Types from 2016 to 2027

    • Table Northwest China Lower GI Series Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Lower GI Series Consumption Share by Types in 2016

    • Figure Northwest China Lower GI Series Consumption Share by Types in 2021

    • Figure Northwest China Lower GI Series Consumption Share by Types in 2027

    • Table Northwest China Lower GI Series Consumption by End-Users from 2016 to 2027

    • Table Northwest China Lower GI Series Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Lower GI Series Consumption Share by End-Users in 2016

    • Figure Northwest China Lower GI Series Consumption Share by End-Users in 2021

    • Figure Northwest China Lower GI Series Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Peacehealth

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Peacehealth

    • Figure Sales and Growth Rate Analysis of Peacehealth

    • Figure Revenue and Market Share Analysis of Peacehealth

    • Table Product and Service Introduction of Peacehealth

    • Table Company Profile and Development Status of Ironwood Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ironwood Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Ironwood Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Ironwood Pharmaceuticals

    • Table Product and Service Introduction of Ironwood Pharmaceuticals

    • Table Company Profile and Development Status of Astrazeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astrazeneca

    • Figure Sales and Growth Rate Analysis of Astrazeneca

    • Figure Revenue and Market Share Analysis of Astrazeneca

    • Table Product and Service Introduction of Astrazeneca

    • Table Company Profile and Development Status of Eisai

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eisai

    • Figure Sales and Growth Rate Analysis of Eisai

    • Figure Revenue and Market Share Analysis of Eisai

    • Table Product and Service Introduction of Eisai

    • Table Company Profile and Development Status of Novadaq

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novadaq

    • Figure Sales and Growth Rate Analysis of Novadaq

    • Figure Revenue and Market Share Analysis of Novadaq

    • Table Product and Service Introduction of Novadaq

    • Table Company Profile and Development Status of Purdue Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Purdue Pharma

    • Figure Sales and Growth Rate Analysis of Purdue Pharma

    • Figure Revenue and Market Share Analysis of Purdue Pharma

    • Table Product and Service Introduction of Purdue Pharma

    • Table Company Profile and Development Status of Cadila Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cadila Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Cadila Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Cadila Pharmaceuticals

    • Table Product and Service Introduction of Cadila Pharmaceuticals


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.